Kinney Horn is Chief Business Officer of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 2,458 shares of OLMA, which is worth approximately $15,067. The most recent transaction as insider was on Mar 10, 2022, when has been sold 5,253 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $24,952. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.46K
0% 3M change
0% 12M change
Total Value Held $15,067

Kinney Horn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2022
SELL
Open market or private sale
$24,952 $4.75 p/Share
5,253 Reduced 68.12%
2,458 Common Stock
Mar 10 2022
BUY
Exercise of conversion of derivative security
$10,821 $2.06 p/Share
5,253 Added 40.52%
7,711 Common Stock
Feb 10 2022
SELL
Sale (or disposition) back to the issuer
-
5,251 Reduced 68.12%
2,458 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
$10,817 $2.06 p/Share
5,251 Added 40.52%
7,709 Common Stock
Jan 10 2022
SELL
Open market or private sale
$35,969 $6.85 p/Share
5,251 Reduced 68.12%
2,458 Common Stock
Jan 10 2022
BUY
Exercise of conversion of derivative security
$10,817 $2.06 p/Share
5,251 Added 40.52%
7,709 Common Stock
Dec 10 2021
SELL
Open market or private sale
$54,558 $10.39 p/Share
5,251 Reduced 68.12%
2,458 Common Stock
Dec 10 2021
BUY
Exercise of conversion of derivative security
$10,817 $2.06 p/Share
5,251 Added 40.52%
7,709 Common Stock
Nov 10 2021
SELL
Open market or private sale
$743,716 $26.88 p/Share
27,668 Reduced 93.92%
1,790 Common Stock
Nov 10 2021
BUY
Exercise of conversion of derivative security
$291,344 $10.53 p/Share
27,668 Added 48.43%
29,458 Common Stock
Oct 11 2021
SELL
Open market or private sale
$146,135 $27.83 p/Share
5,251 Reduced 74.58%
1,790 Common Stock
Oct 11 2021
BUY
Exercise of conversion of derivative security
$10,817 $2.06 p/Share
5,251 Added 42.72%
7,041 Common Stock
Sep 10 2021
SELL
Open market or private sale
$154,274 $29.38 p/Share
5,251 Reduced 74.58%
1,790 Common Stock
Sep 10 2021
BUY
Exercise of conversion of derivative security
$10,817 $2.06 p/Share
5,251 Added 42.72%
7,041 Common Stock
Aug 10 2021
SELL
Open market or private sale
$136,211 $25.94 p/Share
5,251 Reduced 74.58%
1,790 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
$10,817 $2.06 p/Share
5,251 Added 42.72%
7,041 Common Stock
Jul 12 2021
SELL
Open market or private sale
$140,044 $26.67 p/Share
5,251 Reduced 74.58%
1,790 Common Stock
Jul 12 2021
BUY
Exercise of conversion of derivative security
$10,817 $2.06 p/Share
5,251 Added 42.72%
7,041 Common Stock
Jun 10 2021
SELL
Open market or private sale
$153,802 $29.29 p/Share
5,251 Reduced 74.58%
1,790 Common Stock
Jun 10 2021
BUY
Exercise of conversion of derivative security
$10,817 $2.06 p/Share
5,251 Added 42.72%
7,041 Common Stock
May 18 2021
SELL
Open market or private sale
$1,410,572 $24.42 p/Share
57,763 Reduced 96.99%
1,790 Common Stock
May 18 2021
BUY
Exercise of conversion of derivative security
$118,992 $2.06 p/Share
57,763 Added 49.24%
59,553 Common Stock

Also insider at

IMNM
Immunome Inc. Healthcare
KH

Kinney Horn

Chief Business Officer
San Francisco, CA

Track Institutional and Insider Activities on OLMA

Follow Olema Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA